Yahoo
NasdaqGS - Delayed Quote USD

Medline Inc. (MDLN)

39.64 -0.12 (-0.30%)
At close: 4:00:01 PM EST
39.64 -0.01 (-0.03%)
After hours: 4:13:23 PM EST
Trade Medline on Coinbase
MDLN Q3 2026 earnings call
Replay the call for the latest insights.
Read transcript
Chart Range Bar
Loading chart for MDLN
  • Previous Close 39.76
  • Open 39.53
  • Bid 36.08 x 200
  • Ask 41.68 x 200
  • Day's Range 38.31 - 39.85
  • 52 Week Range 31.37 - 50.88
  • Volume 8,946,661
  • Avg. Volume 8,722,890
  • Market Cap (intraday) 52.167B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 90.09
  • EPS (TTM) 0.44
  • Earnings Date Nov 4, 2026
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est 44.65
  • Morningstar Rating Rating available with Stock Picks access

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.

www.medline.com

45,000

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MDLN
5.62%
S&P 500 (^GSPC)
7.76%

1-Year Return

MDLN
13.26%
S&P 500 (^GSPC)
9.77%

3-Year Return

MDLN
13.26%
S&P 500 (^GSPC)
68.96%

5-Year Return

MDLN
13.26%
S&P 500 (^GSPC)
57.04%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 7.86B
Earnings 318M
Profit Margin 4.05%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
2B
4B
6B
2.0%
2.5%
3.0%
3.5%
4.0%

Analyst Insights

View More

Analyst Price Targets

34.00 Low
44.65 Average
39.64 Current
55.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 11/6/2026
Analyst UBS
Rating Action Maintains
Rating Buy
Price Action Raises
Price Target 43 -> 49

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.84%

  • Return on Assets (ttm)

    2.70%

  • Return on Equity (ttm)

    4.84%

  • Revenue (ttm)

    30.68B

  • Net Income Avi to Common (ttm)

    573M

  • Diluted EPS (ttm)

    0.44

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.62B

  • Total Debt/Equity (mrq)

    65.24%

  • Levered Free Cash Flow (ttm)

    1.39B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: